Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies

SIMPLE SUMMARY: Cellular immunotherapy has achieved great progress in the treatment of hematological malignancies, and cell therapy may become the main force in the treatment of refractory and relapsed malignant tumors in the future. The efficacy of CAR T cells as a potential cell therapy in the tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qianzhen, Liu, Zengping, Wan, Rongxue, Huang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496667/
https://www.ncbi.nlm.nih.gov/pubmed/36139611
http://dx.doi.org/10.3390/cancers14184452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496667/
https://www.ncbi.nlm.nih.gov/pubmed/36139611
http://dx.doi.org/10.3390/cancers14184452

Ejemplares similares